Divis Laboratories has commenced commercial operations from a part of the Phase I of Unit III greenfield project at Ontimamidi Village (Kona), Thondangi Mandal, Kakinada, Andhra Pradesh from 01 January 2025. The phase I of the Unit III greenfield project of the Company at Kakinada, Andhra Pradesh is being implemented on 200 acres of 500 acres Unit III site, with an estimated investment between Rs 1,200 crore to Rs 1,500 crore. Powered by Capital Market - Live News

Net profit of Divi`s Laboratories rose 46.55% to Rs 510.00 crore in the quarter ended September 2024 as against Rs 348.00 crore during the previous quarter ended September 2023. Sales rose 22.47% to Rs 2338.00 crore in the quarter ended September 2024 as against Rs 1909.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2338.001909.00 22 OPM %30.6225.09 - PBDT821.00564.00 46 PBT722.00469.00 54 NP510.00348.00 47 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live News

Divis Laboratories has received reaffirmation in credit ratings for bank facilities aggregating Rs 515 crore at CARE AA+; Stable/ CARE A1+ from CARE Ratings. Powered by Capital Market - Live News

Net profit of Divi`s Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as against Rs 356.00 crore during the previous quarter ended June 2023. Sales rose 19.12% to Rs 2118.00 crore in the quarter ended June 2024 as against Rs 1778.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2118.001778.00 19 OPM %29.3728.35 - PBDT701.00585.00 20 PBT604.00492.00 23 NP430.00356.00 21 Powered by Capital Market - Live News